Covered recipient · General Payments record
TERRY W HURT
Allopathic & Osteopathic Physicians Anesthesiology
General Payments · PY2018–2024
$2,213.02
- Reported across 145 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $417.19 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $177.02 | 15 |
| Janssen Biotech, Inc. | $100.12 | 5 |
| Takeda Pharmaceuticals U.S.A., Inc. | $47.94 | 3 |
| Ardelyx, Inc. | $33.47 | 2 |
| Medtronic, Inc. | $21.89 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $19.93 | 1 |
| Ipsen Biopharmaceuticals, Inc | $16.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.64 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103957638 | CMS |
| ABBVIE INC. | $1.49 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103957640 | CMS |
| ABBVIE INC. | $13.66 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103957642 | CMS |
| ABBVIE INC. | $20.06 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103957644 | CMS |
| ABBVIE INC. | $16.25 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103957646 | CMS |
| ABBVIE INC. | $11.83 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103957648 | CMS |
| ABBVIE INC. | $0.36 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103957650 | CMS |
| ABBVIE INC. | $1.12 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103957652 | CMS |
| ABBVIE INC. | $1.75 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103957654 | CMS |
| ABBVIE INC. | $20.04 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103957656 | CMS |
| ABBVIE INC. | $22.28 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103957658 | CMS |
| ABBVIE INC. | $20.79 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103957660 | CMS |
| ABBVIE INC. | $3.21 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103957662 | CMS |
| ABBVIE INC. | $14.69 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103957664 | CMS |
| ABBVIE INC. | $15.85 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103957666 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $19.93 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146989889 | CMS |
| Ardelyx, Inc. | $18.40 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146685693 | CMS |
| Ardelyx, Inc. | $15.07 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146685695 | CMS |
| Ipsen Biopharmaceuticals, Inc | $16.82 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091985539 | CMS |
| Janssen Biotech, Inc. | $14.56 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078804303 | CMS |
| Janssen Biotech, Inc. | $19.76 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078804320 | CMS |
| Janssen Biotech, Inc. | $20.33 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078804212 | CMS |
| Janssen Biotech, Inc. | $22.71 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078804489 | CMS |
| Janssen Biotech, Inc. | $22.76 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078803684 | CMS |
| Medtronic, Inc. | $21.89 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117072096 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.69 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137582431 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.79 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137582435 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.46 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137582438 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.